These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 34682281)
1. Genetic Analyses of Amphotericin B Susceptibility in Fan Y; Korfanty GA; Xu J J Fungi (Basel); 2021 Oct; 7(10):. PubMed ID: 34682281 [No Abstract] [Full Text] [Related]
2. Comparative Genome Sequence Analyses of Geographic Samples of Fan Y; Wang Y; Xu J Microorganisms; 2020 Oct; 8(11):. PubMed ID: 33126611 [TBL] [Abstract][Full Text] [Related]
3. Widespread amphotericin B-resistant strains of Ashu EE; Korfanty GA; Samarasinghe H; Pum N; You M; Yamamura D; Xu J Infect Drug Resist; 2018; 11():1549-1555. PubMed ID: 30288065 [TBL] [Abstract][Full Text] [Related]
4. Identifying genetic variants associated with amphotericin B (AMB) resistance in Chen MM; Shi GH; Dai Y; Fang WX; Wu Q Front Genet; 2023; 14():1133593. PubMed ID: 37229189 [No Abstract] [Full Text] [Related]
5. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B. Abraham OC; Manavathu EK; Cutright JL; Chandrasekar PH Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469 [TBL] [Abstract][Full Text] [Related]
6. Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis. Ambati S; Ellis EC; Pham T; Lewis ZA; Lin X; Meagher RB mBio; 2021 Feb; 12(1):. PubMed ID: 33622715 [TBL] [Abstract][Full Text] [Related]
7. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli. Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437 [TBL] [Abstract][Full Text] [Related]
8. In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies. Colozza C; Posteraro B; Santilli S; De Carolis E; Sanguinetti M; Girmenia C Int J Antimicrob Agents; 2012 May; 39(5):440-3. PubMed ID: 22429723 [TBL] [Abstract][Full Text] [Related]
9. In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods. Bugli F; Posteraro B; Papi M; Torelli R; Maiorana A; Paroni Sterbini F; Posteraro P; Sanguinetti M; De Spirito M Antimicrob Agents Chemother; 2013 Mar; 57(3):1275-82. PubMed ID: 23263007 [TBL] [Abstract][Full Text] [Related]
10. Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B. Singh J; Rimek D; Kappe R Mycoses; 2006 Mar; 49(2):96-103. PubMed ID: 16466441 [TBL] [Abstract][Full Text] [Related]
11. Prior in vitro exposure to voriconazole confers resistance to amphotericin B in Aspergillus fumigatus biofilms. Rajendran R; Mowat E; Jones B; Williams C; Ramage G Int J Antimicrob Agents; 2015 Sep; 46(3):342-5. PubMed ID: 25979638 [TBL] [Abstract][Full Text] [Related]
12. [A pharmacodynamics study of an intravitreal amphotericin B drug delivery system for the treatment of experimental Aspergillus fumigatus endophthalmitis]. Yang X; Dong XG; Liu AM; Sun SY; Xie LX; Wang SG Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):546-53. PubMed ID: 17897534 [TBL] [Abstract][Full Text] [Related]
13. Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy. Ambati S; Ferarro AR; Kang SE; Lin J; Lin X; Momany M; Lewis ZA; Meagher RB mSphere; 2019 Feb; 4(1):. PubMed ID: 30760610 [No Abstract] [Full Text] [Related]
14. Diagnosis and Treatment of Invasive Aspergillosis Caused by Non- Stemler J; Többen C; Lass-Flörl C; Steinmann J; Ackermann K; Rath PM; Simon M; Cornely OA; Koehler P J Fungi (Basel); 2023 Apr; 9(4):. PubMed ID: 37108955 [TBL] [Abstract][Full Text] [Related]
15. Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus. Stergiopoulou T; Meletiadis J; Sein T; Papaioannidou P; Walsh TJ; Roilides E Antimicrob Agents Chemother; 2011 Dec; 55(12):5923-9. PubMed ID: 21911564 [TBL] [Abstract][Full Text] [Related]
17. Antifungal resistance in Aspergillus terreus: A current scenario. Vahedi Shahandashti R; Lass-Flörl C Fungal Genet Biol; 2019 Oct; 131():103247. PubMed ID: 31247322 [TBL] [Abstract][Full Text] [Related]
18. Effects of amphotericin B on Aspergillus flavus clinical isolates with variable susceptibilities to the polyene in an experimental model of systemic aspergillosis. Barchiesi F; Spreghini E; Sanguinetti M; Giannini D; Manso E; Castelli P; Girmenia C J Antimicrob Chemother; 2013 Nov; 68(11):2587-91. PubMed ID: 23794598 [TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole. Carrillo-Muñoz AJ; Quindós G; Tur C; Ruesga M; Alonso R; del Valle O; Rodriguez V; Arévalo MP; Salgado J; Martin-Mazuelos E; Bornay-Llinares FJ; del Palacio A; Cuétara M; Gasser I; Hernández-Molina JM; Pemán J Chemotherapy; 2000; 46(4):235-44. PubMed ID: 10859429 [TBL] [Abstract][Full Text] [Related]